Bio-Rad Laboratories | BIO - Market Capitalization


Bio-Rad Laboratories reported $6.09B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Agilent USD 37.86B 3.64B Dec/2025
Becton, Dickinson and Co. USD 55.29B 1.64B Dec/2025
Bio Techne USD 9.16B 502M Dec/2025
Bruker USD 7.16B 2.23B Dec/2025
Charles River Laboratories USD 10.02B 2.71B Dec/2025
Danaher USD 161.7B 29.34B Dec/2025
General Electric Aerospace USD 324.91B 5.91B Dec/2025
Hologic USD 16.62B 1.67B Dec/2025
Illumina USD 20.62B 6.53B Dec/2025
IQVIA Holdings USD 38.39B 6.1B Dec/2025
Laboratory Of America USD 20.8B 3.03B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Mettler Toledo International USD 28.48B 3.19B Dec/2025
OraSure Technologies USD 219M 45M Mar/2026
Pacific Biosciences Of California USD 356M 209M Mar/2026
Quest Diagnostics USD 19.3B 2.01B Dec/2025
Repligen USD 9.22B 1.7B Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Siemens EUR 191.32B 7.96B Dec/2025
Standard Biotools USD 497M 63M Sep/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Tosoh JPY 764.59B 52.83B Dec/2025
Waters USD 22.61B 5.25B Dec/2025